depression

After skool: Mark Horowitz – common misconceptions about depression & antidepressants

Dr. Mark Horowitz is a training psychiatrist and Clinical Research Fellow in Psychiatry at North East London NHS Foundation Trust. He has a doctorate in the neurobiology of depression and the action of antidepressants from the Institute of Psychiatry, Psychology and Neuroscience at King’s…
Read more

The link between stress and depression … and the 10 simple words that could help

“Neurological insights into how the brain processes stress, and how it can develop into depression, have led to new interventions” This article by Dean Burnett has been published in The Guardian: It begins: “It’s a damp, midweek afternoon. Even so, Cardiff’s…
Read more

Running Therapy For Depression as Effective as Antidepressants Without the Health Risks

This report by Richard Sears has been published by Mad in America. It begins: “An article soon to be published in the Journal of Affective Disorders finds that while running therapy and antidepressants have similar effects on depressive symptoms, running therapy is much…
Read more

‘The medical model has presided over four decades of flat-lining outcomes’

“Author, anthropologist and psychotherapist Dr James Davies tells Fauzia Khan about his journey into the field of mental health and his work as co-founder of the Council for Evidence-based Psychiatry.” The transcript of this interview (conducted by Fauzia Khan) with Dr….
Read more

How a depression test devised by a Zoloft marketer became a crutch for a failing mental health system

This article by Olivia Goldhill has been published by Stat. It begins: “A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick,…
Read more

Australia to allow prescription of MDMA and psilocybin for treatment-resistant mental illnesses

“… the decision will make Australia the first country in the world to officially recognise MDMA and psilocybin as medicines” This report (from Tory Shepherd for The Guardian) begins: “After decades of ‘demonisation’, psychiatrists will be able to prescribe MDMA and…
Read more

Physical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis

This research review paper has been published in JAMA Pediatrics. Key Points: Question:  Can physical activity interventions alleviate depressive symptoms in children and adolescents? Findings:  This systematic review and meta-analysis included 21 studies involving 2441 participants. The results indicate that physical activity interventions were associated…
Read more

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial

This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

This article – from Mark Abie Horowitz, Adele Framer, Michael P. Hengartner, Anders Sørensen & David Taylor – has been published in the journal CNS Drugs. The abstract says: “Adaptation of the brain to the presence of a drug predicts withdrawal…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU